|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.7939 - 0.8533|
|52 Week Range||0.7939 - 3.6500|
|PE Ratio (TTM)||-0.56|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Q2 2017 Regulus Therapeutics Inc Earnings Call
The San Diego-based company said it had a loss of 41 cents per share. The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was ...
President and CEO of Regulus Therapeutics Inc (NASDAQ:RGLS) Joseph P Hagan bought 219,780 shares of RGLS on 07/25/2017 at an average price of $0.91 a share.